SG10201400171PA - Cholestanol derivative for combined use - Google Patents
Cholestanol derivative for combined useInfo
- Publication number
- SG10201400171PA SG10201400171PA SG10201400171PA SG10201400171PA SG10201400171PA SG 10201400171P A SG10201400171P A SG 10201400171PA SG 10201400171P A SG10201400171P A SG 10201400171PA SG 10201400171P A SG10201400171P A SG 10201400171PA SG 10201400171P A SG10201400171P A SG 10201400171PA
- Authority
- SG
- Singapore
- Prior art keywords
- combined use
- cholestanol derivative
- cholestanol
- derivative
- combined
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008055284 | 2008-03-05 | ||
| PCT/JP2009/000985 WO2009110235A1 (en) | 2008-03-05 | 2009-03-04 | Combined use of cholestanol derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201400171PA true SG10201400171PA (en) | 2014-06-27 |
Family
ID=41055800
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013013800A SG188805A1 (en) | 2008-03-05 | 2009-03-04 | Combined use of cholestanol derivative |
| SG10201400171PA SG10201400171PA (en) | 2008-03-05 | 2009-09-03 | Cholestanol derivative for combined use |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013013800A SG188805A1 (en) | 2008-03-05 | 2009-03-04 | Combined use of cholestanol derivative |
Country Status (27)
| Country | Link |
|---|---|
| US (6) | US8088744B2 (en) |
| EP (1) | EP2251014B8 (en) |
| JP (1) | JP5336466B2 (en) |
| KR (1) | KR20100120674A (en) |
| CN (2) | CN101678037B (en) |
| AR (1) | AR070857A1 (en) |
| AU (1) | AU2009220699C1 (en) |
| BR (2) | BRPI0908756A2 (en) |
| CA (1) | CA2717135A1 (en) |
| CO (2) | CO6311080A2 (en) |
| CY (1) | CY1115217T1 (en) |
| DK (1) | DK2251014T3 (en) |
| ES (1) | ES2437640T3 (en) |
| HK (1) | HK1145455A1 (en) |
| HR (2) | HRP20140154T1 (en) |
| IL (1) | IL207874A (en) |
| MX (1) | MX2010009794A (en) |
| NZ (2) | NZ587729A (en) |
| PL (1) | PL2251014T3 (en) |
| PT (1) | PT2251014E (en) |
| RU (1) | RU2492865C2 (en) |
| SG (2) | SG188805A1 (en) |
| SI (1) | SI2251014T1 (en) |
| TW (1) | TWI492759B (en) |
| UA (2) | UA101831C2 (en) |
| WO (1) | WO2009110235A1 (en) |
| ZA (1) | ZA201006228B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ548195A (en) * | 2004-01-14 | 2011-01-28 | Gilead Sciences Inc | Lipid-based dispersions useful for drug delivery |
| PT2404608E (en) * | 2009-03-04 | 2015-07-21 | Otsuka Pharma Co Ltd | Cholestanol derivative for combined use |
| JP5480241B2 (en) * | 2009-03-04 | 2014-04-23 | 大塚製薬株式会社 | Combined use of cholestanol derivatives |
| WO2013179310A1 (en) * | 2012-05-31 | 2013-12-05 | Mylan Laboratories Limited | Stable aqueous compositions of pemetrexed |
| WO2024018412A1 (en) * | 2022-07-20 | 2024-01-25 | University Of The Witwatersrand, Johannesburg | 2-hydroxypropyl-beta-cyclodextrin as a cancer therapy neoadjuvant or adjuvant |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5782310A (en) | 1980-11-11 | 1982-05-22 | Tanabe Seiyaku Co Ltd | Production of liposome preparation |
| JPS6012127A (en) | 1983-06-30 | 1985-01-22 | Dai Ichi Seiyaku Co Ltd | Preparing method of liposome |
| JPS6058915A (en) | 1983-09-12 | 1985-04-05 | Fujisawa Pharmaceut Co Ltd | Lipid microcapsule preparation containing medicament |
| JPH0610131B2 (en) | 1987-10-30 | 1994-02-09 | テルモ株式会社 | Liposomal manufacturing method |
| JPH01167218A (en) | 1987-12-22 | 1989-06-30 | Sumitomo Electric Ind Ltd | Production of superconducting thin film |
| JPH082780B2 (en) | 1990-05-28 | 1996-01-17 | テルモ株式会社 | Liposomal manufacturing method |
| JP3831958B2 (en) | 1995-09-20 | 2006-10-11 | 日本油脂株式会社 | Lipid mixed lipid and liposome dispersion |
| JP4105258B2 (en) * | 1997-08-19 | 2008-06-25 | 大塚製薬株式会社 | Cholestanol compound and medicine containing the same |
| JP4351314B2 (en) | 1998-12-24 | 2009-10-28 | 大塚製薬株式会社 | Cholestanol compound and medicine containing the same |
| EE200200565A (en) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Combination therapy with vascular adverse effects |
| AU2004257509B2 (en) | 2003-07-17 | 2008-12-18 | Otsuka Pharmaceutical Co., Ltd. | Glycoside-containing liposome |
| MXPA06006291A (en) * | 2003-12-08 | 2006-08-23 | Univ Arizona | Synergistic anti-cancer compositions. |
| EP1753512B1 (en) * | 2004-05-28 | 2008-07-09 | Nycomed GmbH | Tetrahydropyridothiophenes |
| TWI373473B (en) * | 2005-09-02 | 2012-10-01 | Otsuka Pharma Co Ltd | Anticancer agent |
-
2009
- 2009-03-03 TW TW098106869A patent/TWI492759B/en not_active IP Right Cessation
- 2009-03-04 CN CN2009800001938A patent/CN101678037B/en not_active Expired - Fee Related
- 2009-03-04 NZ NZ587729A patent/NZ587729A/en unknown
- 2009-03-04 SG SG2013013800A patent/SG188805A1/en unknown
- 2009-03-04 DK DK09718009.5T patent/DK2251014T3/en active
- 2009-03-04 BR BRPI0908756-7A patent/BRPI0908756A2/en not_active IP Right Cessation
- 2009-03-04 MX MX2010009794A patent/MX2010009794A/en active IP Right Grant
- 2009-03-04 PT PT97180095T patent/PT2251014E/en unknown
- 2009-03-04 WO PCT/JP2009/000985 patent/WO2009110235A1/en active Application Filing
- 2009-03-04 JP JP2010501802A patent/JP5336466B2/en not_active Expired - Fee Related
- 2009-03-04 ES ES09718009.5T patent/ES2437640T3/en active Active
- 2009-03-04 KR KR1020107019395A patent/KR20100120674A/en active IP Right Grant
- 2009-03-04 NZ NZ595615A patent/NZ595615A/en unknown
- 2009-03-04 RU RU2010140611/15A patent/RU2492865C2/en not_active IP Right Cessation
- 2009-03-04 CA CA2717135A patent/CA2717135A1/en not_active Abandoned
- 2009-03-04 AR ARP090100765A patent/AR070857A1/en unknown
- 2009-03-04 UA UAA201011673A patent/UA101831C2/en unknown
- 2009-03-04 SI SI200930808T patent/SI2251014T1/en unknown
- 2009-03-04 EP EP09718009.5A patent/EP2251014B8/en not_active Not-in-force
- 2009-03-04 AU AU2009220699A patent/AU2009220699C1/en not_active Ceased
- 2009-03-04 PL PL09718009T patent/PL2251014T3/en unknown
- 2009-03-09 UA UAA201111603A patent/UA101884C2/en unknown
- 2009-09-03 US US12/553,355 patent/US8088744B2/en not_active Expired - Fee Related
- 2009-09-03 BR BRPI0924525A patent/BRPI0924525A2/en not_active IP Right Cessation
- 2009-09-03 CN CN2009800001957A patent/CN101969961B/en not_active Expired - Fee Related
- 2009-09-03 SG SG10201400171PA patent/SG10201400171PA/en unknown
-
2010
- 2010-08-30 IL IL207874A patent/IL207874A/en not_active IP Right Cessation
- 2010-08-31 ZA ZA2010/06228A patent/ZA201006228B/en unknown
- 2010-10-05 CO CO10123058A patent/CO6311080A2/en not_active Application Discontinuation
- 2010-12-21 HK HK10111957.6A patent/HK1145455A1/en not_active IP Right Cessation
-
2011
- 2011-08-25 CO CO11108511A patent/CO6361931A2/en not_active Application Discontinuation
- 2011-09-19 US US13/235,877 patent/US20120009251A1/en not_active Abandoned
- 2011-09-23 US US13/242,184 patent/US20120015025A1/en not_active Abandoned
-
2012
- 2012-12-05 US US13/705,304 patent/US20130101679A1/en not_active Abandoned
-
2014
- 2014-02-18 CY CY20141100126T patent/CY1115217T1/en unknown
- 2014-02-18 HR HRP20140154AT patent/HRP20140154T1/en unknown
- 2014-02-28 US US14/193,512 patent/US20140178464A1/en not_active Abandoned
-
2015
- 2015-04-14 HR HRP20150418TT patent/HRP20150418T1/en unknown
- 2015-09-03 US US14/844,027 patent/US20150374730A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0810902D0 (en) | New compounds | |
| EP2376493A4 (en) | Dihydropyrimidopyrimidine derivative | |
| EP2380877A4 (en) | Pyridine-3-carboxyamide derivative | |
| HK1158189A1 (en) | Morpholinopurine derivative | |
| EP2331543A4 (en) | 3-deazaneplanocin derivatives | |
| EP2291078A4 (en) | Oxazolobenzimidazole derivatives | |
| EP2269993A4 (en) | 2-aminoquinazoline derivative | |
| EP2279532A4 (en) | Oxazolobenzimidazole derivatives | |
| ZA201005769B (en) | Bicycloamine derivative | |
| IL208623A0 (en) | Cyclopentylacrylamide derivative | |
| IL211290A0 (en) | New 2-amidothiadiazole derivatives | |
| IL210344A0 (en) | New compounds | |
| EP2292613A4 (en) | Dihydroindolinone derivatives | |
| SG10201400171PA (en) | Cholestanol derivative for combined use | |
| ZA201006992B (en) | Hydroxyquinoxalinecarboxamide derivative | |
| EP2248811A4 (en) | 2-oxochromene derivative | |
| GB0814728D0 (en) | New combination | |
| IL212683A0 (en) | Biphenylacetamide derivative | |
| GB0823140D0 (en) | New combination | |
| GB0811100D0 (en) | New combination | |
| HU0800478D0 (en) | New compounds | |
| GB0814729D0 (en) | New combination | |
| HK1160019A1 (en) | Cholestanol derivative for combined use | |
| EP2328892A4 (en) | Oxotetrahydrofuran-2-yl-benzimidazole derivative | |
| GB0823141D0 (en) | New combination |